Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...

Bibliografiset tiedot
Päätekijät:	Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Wiley 2022-10-01
Sarja:	Pulmonary Circulation
Aiheet:	idiopathic pulmonary fibrosis interstitial lung disease prostacyclin pulmonary hypertension treprostinil
Linkit:	https://doi.org/10.1002/pul2.12141

Samankaltaisia teoksia

The PH‐ILD Detection tool: External validation and use in patients with ILD
Tekijä: Raj Parikh, et al.
Julkaistu: (2023-07-01)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
Tekijä: Julia McSweeney, et al.
Julkaistu: (2023-04-01)

Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil
Tekijä: Aparna C. Swaminathan, et al.
Julkaistu: (2024-11-01)

Case Report: Selexipag in pediatric pulmonary hypertension: Initiation, transition, and titration
Tekijä: Jenna M. Faircloth, et al.
Julkaistu: (2023-03-01)

Corrigendum: Case report: Selexipag in pediatric pulmonary hypertension: initiation, transition, and titration
Tekijä: Jenna M. Faircloth, et al.
Julkaistu: (2023-08-01)

The Importance of Dose Escalation in the Treatment of Pulmonary Arterial Hypertension with Treprostinil
Tekijä: Piotr Kędzierski, et al.
Julkaistu: (2025-01-01)

Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
Tekijä: Abdullah A. Alqarni, et al.
Julkaistu: (2023-08-01)

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing
Tekijä: Shelsey W. Johnson, et al.
Julkaistu: (2022-07-01)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
Tekijä: Nicholas S. Hill, et al.
Julkaistu: (2022-07-01)

Evolution of pulmonary hypertension in interstitial lung disease: a journey through past, present, and future
Tekijä: Ahmad Arslan, et al.
Julkaistu: (2024-01-01)

PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis
Tekijä: Ning Zhao, et al.
Julkaistu: (2022-11-01)

Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia
Tekijä: Maria S. Nashatyreva, et al.
Julkaistu: (2023-01-01)

Unexpected Acceleration in Treprostinil Delivery Administered by a Lenus Pro® Implantable Pump in Two Patients Treated for Pulmonary Arterial Hypertension
Tekijä: Garance Kopp, et al.
Julkaistu: (2020-10-01)

Reasons for refusing parenteral therapy: a qualitative study of patients with pulmonary arterial hypertension
Tekijä: Kellie Morland, et al.
Julkaistu: (2021-10-01)

Interstitial Lung Abnormality in Asian Population
Tekijä: Gong Yong Jin
Julkaistu: (2024-04-01)

The application of metabolomics toward idiopathic pulmonary fibrosis and potential metabolomic value of diverse samples in interstitial lung diseases
Tekijä: Mingtao Liu, et al.
Julkaistu: (2023-09-01)

CLINICAL PROFILE OF INTERSTITIAL LUNG DISEASES CASES
Tekijä: Gagiya Ashok K, et al.
Julkaistu: (2012-03-01)

Converging Pathways: A Review of Pulmonary Hypertension in Interstitial Lung Disease
Tekijä: Alexandra Lawrence, et al.
Julkaistu: (2024-09-01)

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
Tekijä: Zachary A. Haynes, et al.
Julkaistu: (2023-10-01)

Prostacyclin receptor agonist selexipag in a patient with high-risk idiopathic pulmonary arterial hypertension: a case report
Tekijä: E. A. Rezukhina, et al.
Julkaistu: (2021-09-01)

Interstitial lung diseases with progressive pulmonary fibrosis: pathogenetic features and approaches to therapy
Tekijä: N. A. Kuzubova, et al.
Julkaistu: (2020-11-01)

Therapeutic Potential of Treprostinil Inhalation Powder for Patients with Pulmonary Arterial Hypertension: Evidence to Date
Tekijä: Cassady SJ, et al.
Julkaistu: (2024-06-01)

Osteopontin as a Biomarker in Interstitial Lung Diseases
Tekijä: David Iturbe-Fernández, et al.
Julkaistu: (2024-05-01)

Multidisciplinary discussion for diagnosis of interstitial lung disease in real life
Tekijä: Sabina Anna Guler, et al.
Julkaistu: (2016-05-01)

Increased expiratory flows identify early interstitial lung disease
Tekijä: Sami Mohammed Alyami, et al.
Julkaistu: (2023-01-01)

Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
Tekijä: Sofía Tesolato, et al.
Julkaistu: (2023-12-01)

Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival
Tekijä: Jonathan Keow, et al.
Julkaistu: (2022-06-01)

Evaluation of progressive pulmonary fibrosis in non-idiopathic pulmonary fibrosis-interstitial lung diseases: a cross-sectional study
Tekijä: Özlem Erçen Diken, et al.
Julkaistu: (2024-08-01)

Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role
Tekijä: N A Mukhin, et al.
Julkaistu: (2009-03-01)

Efficacy of oral treprostinil for treating pulmonary arterial hypertension: a systematic review and meta-analysis
Tekijä: Lianghua Xiao, et al.
Julkaistu: (2024-09-01)

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management
Tekijä: Justin M. Oldham, et al.
Julkaistu: (2017-08-01)

Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis
Tekijä: Pierson Richard, et al.
Julkaistu: (2002-02-01)

Abnormal platelet aggregation in pediatric pulmonary hypertension
Tekijä: Stephanie S. Handler, et al.
Julkaistu: (2022-07-01)

Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
Tekijä: Avignat S. Patel, et al.
Julkaistu: (2023-02-01)

Bibliometric analysis of the pirfenidone and nintedanib in interstitial lung diseases
Tekijä: Jia Liu, et al.
Julkaistu: (2024-04-01)

A Case of Interstitial Lung Disease-Related Pulmonary Hypertension Successfully Treated with Inhaled Iloprost
Tekijä: Ji Hoon Jang, et al.
Julkaistu: (2024-08-01)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy
Tekijä: Hardin EA, et al.
Julkaistu: (2016-11-01)

An observational cohort study of interstitial lung abnormalities (ILAs) in a large Japanese health screening population (Kumamoto ILA study in Japan: KILA-J)
Tekijä: Kazuya Ichikado, et al.
Julkaistu: (2023-06-01)

Noninvasive determinants of pulmonary hypertension in interstitial lung disease
Tekijä: Phillip Joseph, et al.
Julkaistu: (2023-01-01)

Pulmonary Hypertension in the Course of Interstitial Lung Diseases—A Personalised Approach Is Needed to Identify a Dominant Cause and Provide an Effective Therapy
Tekijä: Aneta Kacprzak, et al.
Julkaistu: (2023-07-01)